Company Profiles

driven by the PitchBook Platform

Adagene

Adagene
2011 FOUNDED
PRIVATE STATUS
Series B LATEST DEAL TYPE
$28M LATEST DEAL AMOUNT
$36M TOTAL AMOUNT RAISED
5 INVESTORS
Description

Operator of an antibody discovery and engineering company designed to generate, engineer and produce human antibodies. The company's smart antibody technology increases success rates, substantially accelerates time to market and reduces the costs associated with developing a therapeutic antibody, enabling healthcare providers to provide treatment for inflammation and infectious diseases.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
4F, Building C14
218 Xinghu Street, Suzhou Industrial Park
Jiangsu, 215123
China

+85 (0)12 8777 3632
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Adagene’s full profile, request a free trial.

Adagene Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 29-Jan-2016 $28M $36M Completed Startup
2. Early Stage VC (Series A) 08-Dec-2014 000 000 Completed Startup
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Adagene Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Eight Roads Ventures Venture Capital Minority 000 0000 000000 0
F-Prime Capital Partners Venture Capital Minority 000 0000 000000 0
GP Healthcare Capital Venture Capital Minority 000 0000 000000 0
New World TMT Corporation Minority 000 0000 000000 0
WuXi Heathcare Ventures Corporate Venture Capital Minority 000 0000 000000 0

You’re viewing 5 of 5 investors.

Adagene Executive Team (5)

Name Title Board
Seat
Contact
Info
Peter Luo Ph.D Chief Executive Officer, Co-Founder and Board Member
Max Dawson Vice President, Business Development
Yan Li Vice President of Bioinformatics and IT
Kristine She Vice President of Operations
Felix Du Ph.D Vice President of Technology Development

You’re viewing 5 of 5 executives.

Adagene Board Members (5)

Name Representing Role Since Contact
Info
Daniel Auerbach Self Board Member 000 0000
Ge Li Ph.D WuXi AppTec Board Member 000 0000
Peter Luo Ph.D Adagene Chief Executive Officer, Co-Founder and Board Member 000 0000
Thomas Beck MD Self Board Member 000 0000
Xiaoyan Wang Ph.D Self Board Member 000 0000

You’re viewing 5 of 5 board members.